Biotech grants in the United Kingdom
Explore Biotech grants for companies in the United Kingdom. This list brings together funding for drug discovery, diagnostics, cell and gene therapy, biomanufacturing and life-science research from UK innovation agencies, research funders and foundations, international programs open to applicants in the United Kingdom, and competitions any company can enter, with the deadline, award size and eligibility on every listing. Grants aimed at Biotech in the United Kingdom come first.
Showing 193-216 of 799 grants
EIC Pathfinder Challenges
🇪🇺EIC · European Union
Funds European consortia developing breakthrough solutions across AI, climate, energy, materials, medical, and quantum fields.
EIC Accelerator Challenge: Biotech for Regenerating Agricultural Soils
🇪🇺EIC · European Union
Supports scaling deep-tech for soil health, sustainability, and resilience of EU agriculture.
EIC Accelerator Challenges
🇪🇺EIC · European Union
Funds strategic deep-tech challenge projects in materials, energy, biotechnology, and climate innovation.
Innowwide — Next
🇪🇺EUREKA · Global / Multinational
Offers market-feasibility support for small companies exploring non-European markets through Europe-wide innovation networks.
Eureka Network Projects — Permanent
🇪🇺EUREKA · Global / Multinational
Offers open access collaboration through Eureka Network Projects so small enterprises can join international innovation groups.
MSCA Postdoctoral Fellowships — ISERD)
🇪🇺ISERD · Israel
Supports internationally mobile postdoctoral researchers placed in Israeli institutions to build independent research careers through EU mobility fellowships.
The Audacious Project
🇺🇸Audacious Project · United States
Offers The Audacious Project invitation-only multi-issue funding for social-impact ideas with broad partner backing.
Biotechnology for Healthy Soil and Resilient Agriculture
🇪🇺European Commission · European Union
Funds two €6.4M projects that turn soil-friendly biotechnology into scalable, safe and market-ready farm solutions.
AI Predictive Biomarkers for Chronic Diseases
🇪🇺European Commission · European Union
Funds trustworthy AI biomarker methods that predict chronic-disease progression and treatment response for personalised care.
Climate Exposures in the Human Exposome
🇪🇺European Commission · European Union
Funds climate-health exposome research linking lifelong exposures, disease burden, vulnerability and resilience.
Clinical trials for advancing innovative interventions for neurodegenerative diseases
🇪🇺European Commission · European Union
Funds early clinical trials of safer, more effective interventions for non-rare neurodegenerative diseases.
European Partnership for Pandemic Preparedness (Phase 2)
🇪🇺European Commission · European Union
Funds the next phase of Europe’s pandemic-preparedness partnership, clinical networks and One Health research ecosystem.
Horizon Health: Antibody Therapies for Emerging Viruses
🇪🇺European Commission · European Union
Funds €9–10M projects that turn monoclonal antibodies into prevention and treatment options for one emerging virus.
Horizon Health: Cell-Free Protein Synthesis Platforms
🇪🇺European Commission · European Union
Funds €6–8M projects that make cell-free protein synthesis practical for discovering and producing peptide- and protein-based biologicals.
Horizon Health: Flavivirus Antibody Therapies
🇪🇺European Commission · European Union
Funds €9–10M projects that turn monoclonal antibodies into prevention and treatment options for one Flavivirus.
Independent Living and Inclusion for Persons with Disabilities
🇪🇺European Commission · European Union
Funds person-centred health, care and technology that help people with disabilities live independently and belong in their communities.
Innovative Antimicrobials Against Resistant Pathogens
🇪🇺European Commission · European Union
Funds antibacterial and antifungal therapies that expand treatment options against antimicrobial-resistant infections.
Innovative healthcare interventions for non-communicable diseases
🇪🇺European Commission · European Union
Funds €7–8M projects that validate innovative interventions for cardiovascular, metabolic, respiratory or kidney disease.
Novel Small-Molecule Antivirals for Epidemic-Potential Pathogens
🇪🇺European Commission · European Union
Funds small-molecule antivirals that expand preparedness and treatment options for future viral epidemics and pandemics.
Personalised approaches to reduce risks from adverse drug reactions due to multiple medications
🇪🇺European Commission · European Union
Funds safer medication management using biomarkers, clinical data and decision support.
Portable and versatile Point-of-care diagnostics
🇪🇺European Commission · European Union
Funds €5–7M projects that make point-of-care diagnostics more portable, versatile, accurate and useful in clinical practice.
Prevention and management of chronic non-communicable diseases in children and young people
🇪🇺European Commission · European Union
Funds implementation research that helps children and young people prevent and manage chronic disease equitably.
Horizon Bioeconomy: Global Circular Cooperation
🇪🇺European Commission · European Union
Funds a €3M coordination action to connect bio-based industries, international partners and policy makers around fair circular innovation.
Cancer Mission: First-in-Human Trials for Rare Cancers
🇪🇺European Commission · European Union
Funds €7–9M projects taking biomarker-guided rare-cancer treatments into first-in-human, multicentre phase 1 trials.